Immatics Stock Buy Hold or Sell Recommendation
| IMTX Stock | USD 10.79 0.79 6.82% |
Given the investment horizon of 90 days and your highly speculative risk level, our recommendation regarding Immatics NV is 'Buy'. Macroaxis provides Immatics buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Immatics positions. The advice algorithm takes into account all of Immatics' available fundamental, technical, and predictive indicators you will find on this site.
Real Value 12.91 | Target Price 18.8 | Hype Value 10.81 | Market Value 10.79 | Naive Value 10.33 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Immatics NV given historical horizon and risk tolerance towards Immatics. When Macroaxis issues a 'buy' or 'sell' recommendation for Immatics NV, the advice is generated through an automated system that utilizes algorithms and statistical models.
Immatics |
Execute Immatics Buy or Sell Advice
The Immatics recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Immatics NV. Macroaxis does not own or have any residual interests in Immatics NV or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Immatics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Buy
Immatics Trading Alerts and Improvement Suggestions
| Immatics NV generated a negative expected return over the last 90 days | |
| About 25.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: Mainz Biomed Paves The Way For Early Colorectal Cancer Diagnosis And Even Prevention - Mainz Biomed NASD - Benzinga |
Immatics current analysts advice
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Immatics analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Immatics analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Average Consensus Strong Buy
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.
Immatics Returns Distribution Density
The distribution of Immatics' historical returns is an attempt to chart the uncertainty of Immatics' future price movements. The chart of the probability distribution of Immatics stock daily returns describes the distribution of returns around its average expected value. We use Immatics NV price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Immatics returns is essential to provide solid investment advice for Immatics.
| Mean Return | -0.08 | Value At Risk | -4.12 | Potential Upside | 5.26 | Standard Deviation | 2.62 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Immatics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Immatics Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Immatics or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Immatics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Immatics stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | -0.05 | |
β | Beta against NYSE Composite | 0.58 | |
σ | Overall volatility | 2.68 | |
Ir | Information ratio | -0.01 |
Immatics Volatility Alert
Immatics NV exhibits very low volatility with skewness of 0.18 and kurtosis of 0.31. However, we advise investors to further study Immatics NV technical indicators to ensure that all market info is available and is reliable. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Immatics' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Immatics' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.Immatics Fundamentals Vs Peers
Comparing Immatics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Immatics' direct or indirect competition across all of the common fundamentals between Immatics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Immatics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Immatics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Immatics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Immatics to competition |
| Fundamentals | Immatics | Peer Average |
| Return On Equity | -0.43 | -0.31 |
| Return On Asset | -0.12 | -0.14 |
| Profit Margin | (0.85) % | (1.27) % |
| Operating Margin | (0.81) % | (5.51) % |
| Current Valuation | 605.21 M | 16.62 B |
| Shares Outstanding | 80.4 M | 571.82 M |
| Shares Owned by Insiders | 25.22 % | 10.09 % |
| Shares Owned by Institutions | 48.71 % | 39.21 % |
| Number of Shares Shorted | 5.88 M | 4.71 M |
| Price to Earning | 44.61 X | 28.72 X |
| Price to Book | 6.18 X | 9.51 X |
| Price to Sales | 4.70 X | 11.42 X |
| Revenue | 172.83 M | 9.43 B |
| Gross Profit | 172.83 M | 27.38 B |
| EBITDA | 46.34 M | 3.9 B |
| Net Income | 37.51 M | 570.98 M |
| Cash and Equivalents | 324.38 M | 2.7 B |
| Cash per Share | 5.00 X | 5.01 X |
| Total Debt | 14.56 M | 5.32 B |
| Debt to Equity | 0.13 % | 48.70 % |
| Current Ratio | 2.95 X | 2.16 X |
| Book Value Per Share | 2.61 X | 1.93 K |
| Cash Flow from Operations | 100.13 M | 971.22 M |
| Short Ratio | 15.54 X | 4.00 X |
| Earnings Per Share | (1.23) X | 3.12 X |
| Price to Earnings To Growth | 3.00 X | 4.89 X |
| Target Price | 18.29 | |
| Number of Employees | 210 | 18.84 K |
| Beta | 0.5 | -0.15 |
| Market Capitalization | 984.07 M | 19.03 B |
| Total Asset | 407.82 M | 29.47 B |
| Retained Earnings | (500.3 M) | 9.33 B |
| Working Capital | 270.7 M | 1.48 B |
About Immatics Buy or Sell Advice
When is the right time to buy or sell Immatics NV? Buying financial instruments such as Immatics Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.| 2020 | 2021 | 2022 | 2023 (projected) | Current Assets | 238.99 M | 152.21 M | 377.15 M | 308.23 M | Total Assets | 254.65 M | 174.65 M | 407.82 M | 334.22 M |
Use Investing Ideas to Build Portfolios
In addition to having Immatics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Most Shorted Equities Thematic Idea Now
Most Shorted Equities
Dynamically calculated list of top equities currently trending upward via a buy-out by investors. The Most Shorted Equities theme has 125 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Most Shorted Equities Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Immatics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Complementary Tools for Immatics Stock analysis
When running Immatics' price analysis, check to measure Immatics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immatics is operating at the current time. Most of Immatics' value examination focuses on studying past and present price action to predict the probability of Immatics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immatics' price. Additionally, you may evaluate how the addition of Immatics to your portfolios can decrease your overall portfolio volatility.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |
Is Immatics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immatics. If investors know Immatics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immatics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.23) | Revenue Per Share 1.128 | Quarterly Revenue Growth (0.91) | Return On Assets (0.12) | Return On Equity (0.43) |
The market value of Immatics NV is measured differently than its book value, which is the value of Immatics that is recorded on the company's balance sheet. Investors also form their own opinion of Immatics' value that differs from its market value or its book value, called intrinsic value, which is Immatics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immatics' market value can be influenced by many factors that don't directly affect Immatics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immatics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Immatics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immatics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.